Hollander David 4
4 · AERIE PHARMACEUTICALS INC · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Hollander David
Chief R&D Officer
Transactions
- Award
Stock option (right to buy)
2021-02-04+50,000→ 50,000 totalExercise: $17.64Exp: 2031-02-04→ Common Stock (50,000 underlying) - Award
Common Stock
2021-02-04+11,000→ 33,838 total
Footnotes (2)
- [F1]These shares of Common Stock are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of February 4, 2021.
- [F2]This option is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first 48 monthly anniversaries of February 4, 2021.